FDA’s McClellan Calls for More Sharing of Drug R&D Costs
FDA’s McClellan Calls for More Sharing of Drug R&D Costs The U.S. is bearing a disproportionate share of drug research […]
FDA’s McClellan Calls for More Sharing of Drug R&D Costs Read Post »
FDA’s McClellan Calls for More Sharing of Drug R&D Costs The U.S. is bearing a disproportionate share of drug research […]
FDA’s McClellan Calls for More Sharing of Drug R&D Costs Read Post »
Drug Development, Genentech Style “Its promising colon cancer fighter Avastin is a prime example of how the biotech ‘keeps following
BIOTECH THAWS OUT: “Small drug discovery firms are capitalizing on the positive momentum that’s returned to the market for biotechnology
Suit targets 13 generic drug makers “Jumping into the escalating legal battle against pharmaceutical manufacturers, Attorney General Thomas F. Reilly
Judge Allows Antitrust Case Against Seed Producers “A federal judge on Friday let proceed an antitrust case that accused the
Judge Allows Antitrust Case Against Seed Producers Read Post »
Definitions Impede Stem-Cell Work The medical promise of embryonic stem-cell research has been plagued by ethical controversy. Now, an apparent
Bioterror Brain Drain “Infectious-disease specialists are following the big bucks to Washington’s new multibillion-dollar program on bioterrorism research�but at what
A dose of reality “The FDA yesterday opened two days of hearings on the subject of consumer advertising, for the
Naturally blonde, brunette… “Designer ‘therapies’ could one day be helping to restore our hair to its former colour and texture”
Venter Announces $500K Prize for Significant Advances Toward $1,000 Genome “Just before lunch today at the GSAC conference, Craig Venter
Venter Announces $500K Prize for Significant Advances Toward $1,000 Genome Read Post »
Get new actionable insights and updates from BiotechBlog